Literature DB >> 16886166

Is Candida kefyr an emerging pathogen in patients with oncohematological diseases?

Boualem Sendid, Claire Lacroix, Marie-Elisabeth Bougnoux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16886166     DOI： 10.1086/506573

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

1.  Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.

Authors:  Janet F Staab; Dionysios Neofytos; Peter Rhee; Cristina Jiménez-Ortigosa; Sean X Zhang; David S Perlin; Kieren A Marr
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

2.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

3.  Epidemiology of Candida kefyr in patients with hematologic malignancies.

Authors:  Simon F Dufresne; Kieren A Marr; Emily Sydnor; Janet F Staab; Judith E Karp; Kit Lu; Sean X Zhang; Christian Lavallée; Trish M Perl; Dionysios Neofytos
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

4.  Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients.

Authors:  Alexa M G A Laheij; Johannes J de Soet; Peter A von dem Borne; Ed J Kuijper; Eefje A Kraneveld; Cor van Loveren; Judith E Raber-Durlacher
Journal:  Support Care Cancer       Date:  2012-04-26       Impact factor: 3.603

5.  Candidiasis caused by Candida kefyr in a neonate: case report.

Authors:  Stefan Weichert; Konrad Reinshagen; Katrin Zahn; Gernot Geginat; Annebärbel Dietz; Anna Kristina Kilian; Horst Schroten; Tobias Tenenbaum
Journal:  BMC Infect Dis       Date:  2012-03-18       Impact factor: 3.090

6.  Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

Authors:  Michael A Pfaller; David R Andes; Daniel J Diekema; David L Horn; Annette C Reboli; Coleman Rotstein; Billy Franks; Nkechi E Azie
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

7.  An Unusual Case of Candida kefyr Fungemia in an Immunocompromised Patient.

Authors:  Lakshmi Jyothi; Naveen P Reddy; Shazia Naaz
Journal:  Cureus       Date:  2021-03-27

Review 8.  Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature.

Authors:  Anastasia Spiliopoulou; Fevronia Kolonitsiou; Georgia Vrioni; Stamatia Tsoupra; Alexandra Lekkou; Fotini Paliogianni
Journal:  J Mycol Med       Date:  2021-12-23       Impact factor: 3.746

9.  Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.

Authors:  Ali Amanati; Parisa Badiee; Hadis Jafarian; Fatemeh Ghasemi; Samane Nematolahi; Sezaneh Haghpanah; Seyedeh Sedigheh Hamzavi
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

10.  Two missense mutations, E123Q and K151E, identified in the ERG11 allele of an azole-resistant isolate of Candida kefyr recovered from a stem cell transplant patient for acute myeloid leukemia.

Authors:  Célia Couzigou; Frédéric Gabriel; Nicolas Biteau; Valérie Fitton-Ouhabi; Thierry Noël; Isabelle Accoceberry
Journal:  Med Mycol Case Rep       Date:  2014-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.